Osei K. Amponsah

Array ( [id] => 3932536 [patent_doc_number] => 05972601 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Methods and kits for determining the pen polymorphism of human platelet membrane glycoprotein IIIA' [patent_app_type] => 1 [patent_app_number] => 8/484201 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6316 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972601.pdf [firstpage_image] =>[orig_patent_app_number] => 484201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741875 [patent_doc_number] => 05786340 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Gene transfer to the intestine' [patent_app_type] => 1 [patent_app_number] => 8/472163 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 8156 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786340.pdf [firstpage_image] =>[orig_patent_app_number] => 472163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781081 [patent_doc_number] => 05821088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Use of gram-positive bacteria to express recombinant proteins' [patent_app_type] => 1 [patent_app_number] => 8/472244 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7853 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821088.pdf [firstpage_image] =>[orig_patent_app_number] => 472244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932521 [patent_doc_number] => 05972600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Separation of active complexes' [patent_app_type] => 1 [patent_app_number] => 8/482110 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 19 [patent_no_of_words] => 7188 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972600.pdf [firstpage_image] =>[orig_patent_app_number] => 482110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935455 [patent_doc_number] => 05981216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same' [patent_app_type] => 1 [patent_app_number] => 8/483813 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6760 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981216.pdf [firstpage_image] =>[orig_patent_app_number] => 483813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1532176 [patent_doc_number] => 06410326 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Method for inhibiting human tumor cells' [patent_app_type] => B1 [patent_app_number] => 08/486683 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 54 [patent_no_of_words] => 36653 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410326.pdf [firstpage_image] =>[orig_patent_app_number] => 08486683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855194 [patent_doc_number] => 05705385 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer' [patent_app_type] => 1 [patent_app_number] => 8/485458 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 11859 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705385.pdf [firstpage_image] =>[orig_patent_app_number] => 485458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827749 [patent_doc_number] => 05739027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'MTS1E1.beta. gene' [patent_app_type] => 1 [patent_app_number] => 8/487033 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 36357 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739027.pdf [firstpage_image] =>[orig_patent_app_number] => 487033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3847827 [patent_doc_number] => 05766902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Transfection process' [patent_app_type] => 1 [patent_app_number] => 8/487473 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11179 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766902.pdf [firstpage_image] =>[orig_patent_app_number] => 487473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924515 [patent_doc_number] => 05876962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors' [patent_app_type] => 1 [patent_app_number] => 8/486101 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 43 [patent_no_of_words] => 18740 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876962.pdf [firstpage_image] =>[orig_patent_app_number] => 486101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3884142 [patent_doc_number] => 05723292 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Stable DNA constructs' [patent_app_type] => 1 [patent_app_number] => 8/488179 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 15541 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723292.pdf [firstpage_image] =>[orig_patent_app_number] => 488179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407218 [patent_doc_number] => 06309853 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/483211 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 65 [patent_no_of_words] => 61888 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309853.pdf [firstpage_image] =>[orig_patent_app_number] => 483211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3739980 [patent_doc_number] => 05786211 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Adeno-associated virus materials and methods' [patent_app_type] => 1 [patent_app_number] => 8/475391 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5889 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786211.pdf [firstpage_image] =>[orig_patent_app_number] => 475391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3955752 [patent_doc_number] => 05935935 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Adenoviral vectors for treatment of hemophilia' [patent_app_type] => 1 [patent_app_number] => 8/484891 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 74 [patent_no_of_words] => 29367 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935935.pdf [firstpage_image] =>[orig_patent_app_number] => 484891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3789890 [patent_doc_number] => 05780229 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Polynucleotides for determining the pen polymorphism of human platelet membrane glycoprotein IIIa' [patent_app_type] => 1 [patent_app_number] => 8/482174 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6329 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780229.pdf [firstpage_image] =>[orig_patent_app_number] => 482174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4057720 [patent_doc_number] => 05866131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Recombinant vaccine' [patent_app_type] => 1 [patent_app_number] => 8/473301 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 9136 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866131.pdf [firstpage_image] =>[orig_patent_app_number] => 473301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355655 [patent_doc_number] => 06174685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/467528 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 2686 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174685.pdf [firstpage_image] =>[orig_patent_app_number] => 467528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937166 [patent_doc_number] => 05871976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Autocatalytic replication of recombinant RNA' [patent_app_type] => 1 [patent_app_number] => 8/467816 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9621 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871976.pdf [firstpage_image] =>[orig_patent_app_number] => 467816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3643588 [patent_doc_number] => 05683700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Expression of recombinant proteins in attenuated bacteria' [patent_app_type] => 1 [patent_app_number] => 8/469507 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4168 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683700.pdf [firstpage_image] =>[orig_patent_app_number] => 469507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723104 [patent_doc_number] => 05670149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Lymphotoxin-.beta., Lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/476489 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 31 [patent_no_of_words] => 21898 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670149.pdf [firstpage_image] =>[orig_patent_app_number] => 476489 [rel_patent_id] =>[rel_patent_doc_number] =>)